NL-OMON46451撤回不适用
The pathogenesis of B-cell non-Hodgkin lymphoma after exposure to C. burnetii: a micro-array study to unravel the genetic pathway - Genetic pathway of NHL after Q fever
Jeroen Bosch Ziekenhuis0 个研究点目标入组 7 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •prior history of non-Hodgkin lymphoma; past exposure to C. burnetii, determined with serology; signed informed consent
排除标准
- •< 18 years of age; legal incapability; current treatment with cytostatics for other malignancy (burden for patients too high)
研究者
相似试验
进行中（未招募）
1 期
Diffuse large B cell non-hodgkin's lymphoma in the vulnerable/frail elderly. A multicentrix randomized phase II trial with emphasis on geritaric assesment and quality of life. - FRAIL 06Vulnerable/Frail elderly patients older than 70 with diffuse large B-cell lymphoma stage II, III, or IVMedDRA version: 9.1Level: LLTClassification code 10029547Term: Non-Hodgkin's lymphomaEUCTR2008-001506-16-FRInstitut Bergonié120
进行中（未招募）
1 期
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaNCT06667687AbbVie21
进行中（未招募）
不适用
BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.Non Hodgkin LymphomaMarginal Zone LymphomaDiffuse Large B Cell LymphomaFollicular LymphomaNCT06424379Hospices Civils de Lyon135
进行中（未招募）
1 期
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesHematologic CancerNCT05753501AbbVie135
招募中
3 期
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsHigh Grade B-Cell Lymphoma, Not Otherwise SpecifiedDiffuse Large B-cell LymphomaB-cell NonHodgkin LymphomaMantle Cell LymphomaNCT05097443Shandong Provincial Hospital130